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Abstract
Introduction: Burkitt's lymphoma is a form of non-Hodgkin's B-cell lymphoma with more than
one identifiable variant. The sporadic form most commonly presents with abdominal lymph node
involvement.
Case reports: We herein report on three patients from our experience that presented with
either endobronchial or colonic Burkitt's lymphoma. Their clinical presentation mimicked that of
other syndromes. After confirmatory pathological diagnosis, the patients had complete remission
through the use of an optimal treatment protocol.
Conclusion: Our review of the cases and comparable reports warrants careful workup of such
presentations to ensure early diagnosis and therapeutic planning of this highly aggressive disease.
Introduction
Burkitt's lymphoma is an aggressive form of non-Hodg-
kin's B-cell lymphoma that is usually diagnosed in chil-
dren and young adults, and to a lesser extent in middle-
aged adults. Endemic, sporadic (non-endemic) and
immunodeficient variants have been recognized [1].
Burkitt's lymphomas occurring in non-endemic areas,
most commonly in developed countries, are believed to
be histologically identical to those in endemic areas,
found predominantly in equatorial Africa [2]. They are
recognized as small non-cleaved cell lymphomas display-
ing a starry sky appearance due to the high rate of prolif-
eration and spontaneous cell death. Chromosomal
translocations involving the MYC oncogene are believed
to highlight the hallmark of the disease [3]. However; the
clinical presentation of Burkitt's lymphoma will differ
depending upon the specific variant. In endemic areas, it
usually involves the facial bones, particularly the jaw,
maxilla, and orbit, especially in young children [2]. This
variant has been associated with Epstein-Barr virus (EBV)
infection, as well as frequent concomitant malaria infec-
tion [4]. In comparison, the sporadic form tends to
present in the lymphoid tissues of the gut, often present-
ing as masses in the Waldeyer ring or the terminal ileum,
or even with massive abdominal involvement. Bone mar-
row involvement is commonly seen in progressive disease
[5]. EBV involvement is reported in around 15–30% of
cases [6]. The immunodeficient form is often associated
with HIV infection, and may also be seen in post-trans-
plant patients who are chronically immunosuppressed.
Generalized lymphadenopathy is usually noted in this
variant [7]. We herein report three cases of sporadic
Burkitt's lymphoma presenting in a manner different
from that commonly described. Comparison with previ-
ous similar reports is then discussed.
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Case presentation
Patient 1
Patient 1 is a 62-year-old woman who presented with a
few days history of right facial swelling and dyspnea. The
patient underwent left radical mastectomy twenty years
prior to presentation for a moderately differentiated stage
IIB adenocarcinoma. Computed tomography (CT) scan of
the chest showed a large mediastinal mass 5 × 3.5 cm in
dimension invading the superior vena cava, right pulmo-
nary artery, and the right main bronchus, with multiple
lung nodularity. Bronchoscopic examination revealed a
fungating mass intruding into the orifice of the right main
bronchus causing partial obstruction. Pathologic exami-
nation of the biopsy sample revealed high-grade, non-
Hodgkin, B-cell lymphoma. Immunohistochemical test-
ing was positive for CD45, CD20, CD10, and BCL-6, and
negative for CD3, TdT, and BCL-2; which was consistent
with Burkitt's lymphoma. Cerebrospinal fluid (CSF) stud-
ies were always negative for lymphoma. No evidence of
lymphoma was noted in the bone marrow. Chemo-
immunotherapy with hyper-CVAD (hyper-fractionated
cyclophosphamide, vincristine, doxorubicin, dexametha-
sone) plus rituximab were given according to the Thomas
et al. protocol [8] for 8 cycles. The patient had multiple
successive admissions for febrile neutropenia and is cur-
rently in complete remission (CR), defined as complete
disappearance of all known disease.
Patient 2
Patient 2 is a 16-year-old boy who presented with signs
and symptoms of acute appendicitis. Appendectomy was
performed on an emergent basis and the tissue was sent to
pathology. Diffuse lymphoreticular infiltration of the
mucosa of the appendix penetrating the muscularis of the
cecal end and extending to the adjacent fatty tissue was
noted. High-grade, non-Hodgkin, B-cell lymphoma was
described. Immunohistochemical testing was positive for
CD45, CD20, CD10, and BCL-6, and negative for CD3,
TdT, and BCL-2; which was consistent with Burkitt's lym-
phoma. CSF and bone marrow studies were negative. The
patient received hyper-CVAD plus rituximab according to
the Thomas et al. protocol [8] for 8 cycles. The patient has
been in CR after completion of chemotherapy.
Patient 3
Patient 3 is a 37-year-old male patient who presented with
right lower quadrant pain, that is colicky in nature and
radiating to the whole abdomen. Rectal bleeding was also
reported. CT scan of the abdomen showed a 4.4 × 4.1 cm
cecal mass with small adjacent lymph nodes, the largest
measuring 1.4 × 0.6 cm. Colonoscopy revealed a large ile-
ocecal mass. Biopsy results showed a diffuse lamina pro-
pria lymphoid infiltrate with intermediate size cells that
are mildly pleomorphic with prominent central
basophilic nucleoli and brisk mitotic activity. Immuno-
histochemically, high-grade non-Hodgkin B-cell lym-
phoma that is CD45, CD20, CD10, and BCL-6 positive
was noted. The cells were negative for CD3, CD 5, BCL-2.
KI-67 proliferation index was positive in all tumor cells.
The diagnosis of Burkitt's lymphoma was entertained. CSF
and bone marrow studies were negative. The patient
received hyper-CVAD plus rituximab according to the
Thomas et al. protocol [8] for 8 cycles. Pancytopenia, neu-
tropenia, and thrombocytopenia were the main reasons
for three consecutive hospital admissions. Repeat colon-
oscopy and CT scan 4 months post initiation of chemo-
therapy showed no evidence of disease.
Discussion
Sporadic Burkitt's lymphoma accounts for 1%–2% of
lymphoma in adults and up to 40% of lymphoma in chil-
dren in the United States and western Europe [1]. The
abdomen, mainly the ileocecal area, is the most common
presenting site; the ovaries, kidneys, omentum, Wal-
deyer's ring, have also been reported. Malignant pleural
effusions or ascites have been the presenting signs in some
patients. Bilateral involvement of the breasts may occur in
association with the onset of puberty or with lactation.
Central nervous system (CNS) involvement has also been
noted [9]. Lymph node involvement is more common in
Table 1: Characteristics of endobronchial Burkitt's lymphoma.
Reference Patient 1 (this report) Richet-Boe et al. [12]
Age 62 52
Sex FM
Anatomic location Endobronchial Endobronchial
Clinical presentation SVC syndrome Dyspnea, cough
Bone marrow Neg Pos
CSF Neg Pos
EBV Neg not done
Treatment Hyper-CVAD + rituximab CVAD
Follow up CR Mortality
SVC = superior vena cava; CSF = cerebrospinal fluid; EBV = Epstein-Barr virus; CVAD = cyclophosphamide, vincristine, doxorubicin, 
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adults, where as children usually present with extranodal
disease [9]. Leukemic Burkitt's lymphoma has also been
described and assigned type L3 in acute lymphoblastic
leukemias [9]. Bronchial (Table 1) and colonic (Table 2)
wall involvement have only been described in few reports
including ours.
The endobronchial involvement in our first patient, with
simultaneous mediastinal extension, resulted in what is
known as superior vena cava syndrome (SVC syndrome),
which is a complication of many mediastinal disease
resulting in the obstruction of the superior vena cava with
various subsequent signs and symptoms. Malignancy is
the etiology in 60% of the cases, with bronchogenic carci-
noma having the highest frequency. Small-cell and non-
small cell lung cancer account for 22% and 24% of the
cases, respectively. Lymphomas involvement is noted in
8% of the cases [10]. Endobronchial involvement of
Hodgkin's lymphomas has been previously reported [11];
however, our patient and that of Richet-Boe et al. [12] rep-
resent the only Burkitt's cases. Our patient had absence of
disease in the bone marrow and CSF and was treated with
the addition of rituximab to hyper-CVAD which has been
shown to improve outcome in Burkitt's lymphoma, espe-
cially in adult patients, with a complete response rate of
86% [8]. Any of these parameters might explain the favo-
rable remission in our patient.
Abdominal symptoms are a frequent initial complaint in
Burkitt's lymphoma. However, an acute surgical abdomen
is a rare presentation. Our second patient and the patient
reported by Dunning et al. [13] presented with signs and
symptoms of colonic ischemia resulting from lymphoid
infiltration of the bowl wall. The case reported by Chang
et al. [14] had an underlying intussusception. The uncom-
mon presentations in the three cases called for emergent
surgery. If the diagnosis of Burkitt's lymphoma was ini-
tially highly suspected, small tumors that are localized
and can be safely resected may benefit from complete sur-
gical resection. However, extensive abdominal involve-
ment with presumed Burkitt's lymphoma or metastatic
disease should undergo a limited biopsy followed by
chemotherapy rather than an aggressive attempt to resect
or debulk the tumor [13]. Mortality after emergency
laparotomy in the setting of untreated Burkitt's lym-
phoma was found to be very high. It was presumed to be
due to tumor lysis syndrome which can occur after surgi-
cal manipulation of the tumor [15].
Conclusion
Burkitt's lymphoma is an extremely rapidly growing
tumor with a high sensitivity to chemotherapy but in
which drug resistance can develop quickly. These dynamic
features make prompt diagnosis and initiation of appro-
priate therapy essential for optimal outcome. Our report
and review highlighted some unusual presentations of
this tumor that should be kept in mind when compiling a
differential diagnosis for similar presentations. Pathologic
and immunohistochemical testing remain the only defin-
itive methods of diagnosis. The choice between surgical,
chemotherapeutic and chemo-immunotherapeutic treat-
ment should be individualized.
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Table 2: Characteristics of colonic Burkitt's lymphoma.
Reference Patient 2 (this report) Patient 3 (this report) Dunning et al. [13] Chang et al. [14]
Age 16 37 14 23
Sex MM M F
Anatomic location Appendix Ileocecum Ileocecum Ileocecum
Clinical presentation Acute appendicitis Abdominal pain, rectal 
bleeding
Colonic ischemia, cardiac 
arrest, sepsis
Abdominal pain, 
Intussusception
Bone marrow Neg Neg Neg Neg
CSF Neg Neg Neg Neg
EBV Neg Neg not done pos
Treatment Appendectomy + Hyper-CVAD 
+ rituximab
Hyper-CVAD + rituximab Ileocecal resection Hemicoloectomy + CHOP
Follow up CR CR Brain death CR
CSF = cerebrospinal fluid; EBV = Epstein-Barr virus; CVAD = cyclophosphamide, vincristine, doxorubicin, dexamethasone; CHOP = 
cyclophosphamide, vincristine, prednisone; CR = complete remission.Publish with BioMed Central    and   every 
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